Sentinel Node Biopsy

Global Sentinel Node Biopsy Market to Reach US$1.3 Billion by 2030

The global market for Sentinel Node Biopsy estimated at US$829.3 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Surgical Instruments, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$732.2 Million by the end of the analysis period. Growth in the Imaging Agents segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$218.0 Million While China is Forecast to Grow at 6.9% CAGR

The Sentinel Node Biopsy market in the U.S. is estimated at US$218.0 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$200.3 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.7% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Sentinel Node Biopsy Market – Key Trends & Drivers Summarized

Why Is Sentinel Node Biopsy Becoming A Crucial Procedure In Cancer Diagnostics?

Sentinel node biopsy (SNB) is a minimally invasive surgical procedure used to determine the spread of cancer, particularly in cases of breast cancer and melanoma. By identifying and analyzing the first lymph node (sentinel node) that cancer cells are likely to reach, SNB helps physicians assess metastasis without requiring a full lymph node dissection. This technique is gaining popularity due to its ability to reduce complications such as lymphedema while maintaining high diagnostic accuracy. With cancer rates rising globally and early detection playing a critical role in improving survival rates, the demand for sentinel node biopsy procedures is growing across healthcare institutions. Additionally, advancements in imaging and molecular diagnostics are further improving SNB precision and reliability.

What Technological Innovations Are Enhancing Sentinel Node Biopsy Procedures?

Recent advancements in radiotracer technology, fluorescence-guided surgery, and molecular imaging are revolutionizing sentinel node biopsy. The use of hybrid tracers combining radioactive and fluorescent dyes is improving detection rates, allowing surgeons to precisely locate sentinel lymph nodes. AI-assisted pathology analysis is further enhancing the accuracy of biopsy results, leading to better cancer staging and treatment planning. Additionally, robotic-assisted sentinel node biopsies are being explored to improve precision and minimize patient trauma. These technological breakthroughs are making SNB more efficient, accurate, and widely accessible in oncology practices.

Which Medical Sectors Are Driving The Growth Of Sentinel Node Biopsy?

Breast cancer diagnosis remains the leading application of sentinel node biopsy, with SNB becoming the standard of care for early-stage breast cancer patients. Dermatology and oncology practices are also utilizing SNB for melanoma staging, as it allows for precise assessment of lymph node involvement. Emerging applications in head and neck cancer, gynecologic cancers, and prostate cancer are further expanding the use of SNB. Additionally, healthcare providers in emerging markets are adopting SNB as part of improved cancer care strategies, supported by growing investments in oncology infrastructure.

What Factors Are Fueling The Growth Of The Sentinel Node Biopsy Market?

The growth of the sentinel node biopsy market is being driven by increasing cancer prevalence, rising adoption of minimally invasive diagnostic procedures, and advancements in imaging technology. Government initiatives promoting early cancer detection and improved access to oncology diagnostics are further supporting market expansion. Additionally, the integration of AI and machine learning in pathology is enhancing SNB accuracy, driving demand among oncologists and surgeons. As precision medicine continues to evolve, SNB will play an increasingly crucial role in personalized cancer treatment and prognosis.

SCOPE OF STUDY:

The report analyzes the Sentinel Node Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Surgical Instruments, Imaging Agents, Diagnostic Kits); Procedure (Open Surgery, Minimally Invasive Surgery); Application (Breast Cancer, Colon Cancer, Esophageal Cancer, Others); End-Use (Hospitals & Clinics, Ambulatory Surgery Centers, Diagnostic Centers)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 39 Featured) -

• BD (Becton, Dickinson and Company)
• Boston Scientific Corporation
• C.R. Bard, Inc.
• Cardinal Health
• Care Wise
• Devicor Medical Products, Inc.
• Devicor Medical Products, Inc.
• Endomagnetics Ltd (Endomag)
• Gamma Medical Technology
• Gamma Probe Technologies
• GE Healthcare
• Hologic, Inc.
• Hologic, Inc.
• Intramedical Imaging LLC
• IsoRay Medical
• KUB Technologies Inc.
• KUB Technologies Inc.
• LabLogic Systems Ltd (Care Wise)
• LabLogic Systems Ltd (Care Wise)
• LymphaTech
• Medtronic
• Navidea Biopharmaceuticals, Inc.
• Philips Healthcare
• Senti Biosciences
• Siemens Healthineers
• Stryker Corporation
• Stryker Corporation
• SurgicEye GmbH
• SurgicEye GmbH
• Varay Laborix

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.